4//SEC Filing
HERBALIFE LTD. 4
Accession 0001209191-17-031677
$HLFCIK 0001180262operating
Filed
May 10, 8:00 PM ET
Accepted
May 11, 8:34 PM ET
Size
27.6 KB
Accession
0001209191-17-031677
Insider Transaction Report
Form 4
Alzarez Jesus
VP, General Manager, Mexico
Transactions
- Exercise/Conversion
Common Stock
2017-05-09$30.44/sh+1,957$59,571→ 2,432 total - Sale
Common Stock
2017-05-11$71.53/sh−1,214$86,837→ 0 total - Exercise/Conversion
Stock Appreciation Rights
2017-05-09−3,464→ 0 totalExercise: $59.98From: 2017-04-30Exp: 2024-04-30→ Common Stock (3,464 underlying) - Exercise/Conversion
Stock Appreciation Rights
2017-05-09−1,957→ 5,873 totalExercise: $30.44From: 2017-03-02Exp: 2025-03-02→ Common Stock (1,957 underlying) - Exercise/Conversion
Common Stock
2017-05-09$62.51/sh+873$54,571→ 873 total - Disposition to Issuer
Common Stock
2017-05-09$72.81/sh−750$54,608→ 123 total - Tax Payment
Common Stock
2017-05-09$72.81/sh−44$3,204→ 79 total - Exercise/Conversion
Common Stock
2017-05-09$59.98/sh+3,464$207,771→ 3,543 total - Disposition to Issuer
Common Stock
2017-05-09$72.81/sh−2,854$207,800→ 689 total - Tax Payment
Common Stock
2017-05-09$72.81/sh−214$15,581→ 475 total - Disposition to Issuer
Common Stock
2017-05-09$72.81/sh−819$59,631→ 1,613 total - Tax Payment
Common Stock
2017-05-09$72.81/sh−399$29,051→ 1,214 total - Exercise/Conversion
Stock Appreciation Rights
2017-05-09−873→ 3,493 totalExercise: $62.51From: 2017-05-09Exp: 2026-05-09→ Common Stock (873 underlying)
Footnotes (6)
- [F1]The reporting person received 79 shares of common stock upon the net exercise of the 873 stock appreciation rights ("SARs"). The reporting person forfeited 750 shares of common stock underlying Stock Appreciation Rights ("SARS") in payment of the exercise price and 44 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on May 9, 2017 of $72.81.
- [F2]The reporting person received 396 shares of common stock upon the net exercise of the 3,464 SARS. The reporting person forfeited 2,854 shares of common stock underlying the SARS in payment of the exercise price and 214 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on May 9, 2017 of $72.81.
- [F3]The reporting person received 739 shares of common stock upon the net exercise of the 1,957 SARS. The reporting person forfeited 819 shares of common stock underlying the SARS in payment of the exercise price and 399 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on May 9, 2017 of $72.81.
- [F4]This transaction was executed in multiple trades at prices ranging from $71.52 to $71.53. The price reported reflects the weighted average sale price of $71.5275. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F5]Consists of 4,366 stock appreciation rights granted under the Herbalife Ltd. 2014 Stock Incentive Plan, of which 20% vested on May 9, 2017, 20% will vest on May 9, 2018, and the remaining 60% will vest on May 9, 2019.
- [F6]Consists of 9,787 stock appreciation rights granted under the Herbalife Ltd. 2014 Stock Incentive Plan, of which 20% vested on March 2, 2016, 20% vested on March 2, 2017, and the remaining 60% will vest on March 2, 2018.
Documents
Issuer
HERBALIFE LTD.
CIK 0001180262
Entity typeoperating
IncorporatedCayman Islands
Related Parties
1- filerCIK 0001180262
Filing Metadata
- Form type
- 4
- Filed
- May 10, 8:00 PM ET
- Accepted
- May 11, 8:34 PM ET
- Size
- 27.6 KB